11
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Planar cell polarity (PCP) pathways control the orientation and alignment of epithelial cells within tissues. Van Gogh‐like 2 (Vangl2) is a key PCP protein that is required for the normal differentiation of kidney glomeruli and tubules. Vangl2 has also been implicated in modifying the course of acquired glomerular disease, and here, we further explored how Vangl2 impacts on glomerular pathobiology in this context. Targeted genetic deletion of Vangl2 in mouse glomerular epithelial podocytes enhanced the severity of not only irreversible accelerated nephrotoxic nephritis but also lipopolysaccharide‐induced reversible glomerular damage. In each proteinuric model, genetic deletion of Vangl2 in podocytes was associated with an increased ratio of active‐MMP9 to inactive MMP9, an enzyme involved in tissue remodelling. In addition, by interrogating microarray data from two cohorts of renal patients, we report increased VANGL2 transcript levels in the glomeruli of individuals with focal segmental glomerulosclerosis, suggesting that the molecule may also be involved in certain human glomerular diseases. These observations support the conclusion that Vangl2 modulates glomerular injury, at least in part by acting as a brake on MMP9, a potentially harmful endogenous enzyme. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: found
          • Article: not found

          Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

          Matrix metalloproteinases are an important group of zinc enzymes responsible for degradation of the extracellular matrix components such as collagen and proteoglycans in normal embryogenesis and remodeling and in many disease processes such as arthritis, cancer, periodontitis, and osteoporosis. A matrixin family is defined, comprising at least seven members that range in size from Mr 28,000 to 92,000 and are related in gene sequence to collagenase. All family members are secreted as zymogens that lose peptides of about 10,000 daltons upon activation. Latency is due to a conserved cysteine that binds to zinc at the active center. Latency is overcome by physical (chaotropic agents), chemical (HOCl, mercurials), and enzymatic (trypsin, plasmin) treatments that separate the cysteine residue from the zinc. Expression of the metalloproteinases is switched on by a variety of agents acting through regulatory elements of the gene, particularly the AP-1 binding site. A family of protein inhibitors of Mr 28,500 or less binds strongly and stoichiometrically in noncovalent fashion to inhibit members of the family. The serum protein alpha 2-macroglobulin and relatives are also strongly inhibitory.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice.

            Inflammation plays a critical role in the development of cardiovascular diseases. Infiltration of leukocytes to sites of injury requires their exit from the blood and migration across basement membrane; this process has been postulated to require remodeling of the ECM. Plasminogen (Plg) is a protease that binds to the ECM and, upon conversion to plasmin, degrades multiple ECM proteins. In addition, plasmin directly activates MMPs. Here, we used Plg(-/-) mice to investigate the role of Plg in inflammatory leukocyte migration. After induction of peritonitis by thioglycollate injection, we found that Plg(-/-) mice displayed diminished macrophage trans-ECM migration and decreased MMP-9 activation. Furthermore, injection of the active form of MMP-9 in Plg(-/-) mice rescued macrophage migration in this model. We used periaortic application of CaCl2 to induce abdominal aortic aneurysm (AAA) and found that Plg(-/-) mice displayed reduced macrophage infiltration and were protected from aneurysm formation. Administration of active MMP-9 to Plg(-/-) mice promoted macrophage infiltration and the development of AAA. These data suggest that Plg regulates macrophage migration in inflammation via activation of MMP-9, which, in turn, regulates the ability of the cells to migrate across ECM. Thus, targeting the Plg/MMP-9 pathway may be an attractive approach to regulate inflammatory responses and AAA development.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Convergent extension, planar-cell-polarity signalling and initiation of mouse neural tube closure.

              Planar-cell-polarity (PCP) signalling is necessary for initiation of neural tube closure in higher vertebrates. In mice with PCP gene mutations, a broad embryonic midline prevents the onset of neurulation through wide spacing of the neural folds. In order to evaluate the role of convergent extension in this defect, we vitally labelled the midline of loop-tail (Lp) embryos mutant for the PCP gene Vangl2. Injection of DiI into the node, and electroporation of a GFP expression vector into the midline neural plate, revealed defective convergent extension in both axial mesoderm and neuroepithelium, before the onset of neurulation. Chimeras containing both wild-type and Lp-mutant cells exhibited mainly wild-type cells in the midline neural plate and notochordal plate, consistent with a cell-autonomous disturbance of convergent extension. Inhibitor studies in whole-embryo culture demonstrated a requirement for signalling via RhoA-Rho kinase, but not jun N-terminal kinase, in convergent extension and the onset of neural tube closure. These findings identify a cell-autonomous defect of convergent extension, requiring PCP signalling via RhoA-Rho kinase, during the development of severe neural tube defects in the mouse.
                Bookmark

                Author and article information

                Contributors
                e.papakrivopoulou@ucl.ac.uk
                d.long@ucl.ac.uk
                Journal
                J Pathol
                J. Pathol
                10.1002/(ISSN)1096-9896
                PATH
                The Journal of Pathology
                John Wiley & Sons, Ltd (Chichester, UK )
                0022-3417
                1096-9896
                16 November 2018
                December 2018
                : 246
                : 4 ( doiID: 10.1002/path.2018.246.issue-4 )
                : 485-496
                Affiliations
                [ 1 ] Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health London UK
                [ 2 ] Medway School of Pharmacy University of Kent Chatham Maritime UK
                [ 3 ] Nephrological Center, Medical Clinic and Policlinic IV University of Munich Munich Germany
                [ 4 ] Department of Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany
                [ 5 ] Electron Microscopy Research Services Newcastle University Newcastle upon Tyne UK
                [ 6 ] Cardiovascular Research Centre Institute of Genetic Medicine, Newcastle University Newcastle upon Tyne UK
                [ 7 ] Inflammation Repair and Development Section National Heart and Lung Institute, Imperial College London London UK
                [ 8 ] University College London Centre for Nephrology, Royal Free Hospital London UK
                [ 9 ] Faculty of Biology Medicine and Health School of Biological Sciences, University of Manchester Manchester UK
                [ 10 ] Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre Manchester UK
                Author notes
                [*] [* ]Correspondence to: E Papakrivopoulou or DA Long, Developmental Biology and Cancer Programme, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. E‐mail: e.papakrivopoulou@ 123456ucl.ac.uk or d.long@ 123456ucl.ac.uk
                Author information
                https://orcid.org/0000-0001-6580-3435
                Article
                PATH5158
                10.1002/path.5158
                6282744
                30125361
                8c18b255-534e-41b6-85ac-3b0def6da51c
                © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 25 February 2018
                : 02 August 2018
                : 10 August 2018
                Page count
                Figures: 5, Tables: 1, Pages: 12, Words: 8100
                Funding
                Funded by: Kidney Research UK
                Award ID: PDF8/2015 SF1/2008
                Award ID: SF1/2008
                Funded by: Medical Research Council
                Award ID: MR/J003638/1 MR/L002744/1MR/P018629/1
                Award ID: MR/P018629/1
                Award ID: MR/J003638/1
                Funded by: National Institute for Health Research Biomedical Research Centre
                Funded by: Wellcome Trust
                Award ID: 095949/Z/11/Z
                Funded by: Else Kröner Fresenius Foundation
                Funded by: Manchester Biomedical Research Centre and the Manchester Academic Health Science Centre
                Funded by: MRC
                Award ID: MR/L002744/1
                Funded by: University College London
                Funded by: National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust
                Funded by: KRUK Postdoctoral Fellowship
                Award ID: PDF8/2015
                Funded by: Kids Kidney Research
                Funded by: Wellcome Trust
                Award ID: 095949/Z/11/Z
                Categories
                Original Paper
                Original Papers
                Custom metadata
                2.0
                path5158
                December 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.3 mode:remove_FC converted:06.12.2018

                Pathology
                glomerulus,kidney disease,matrix metalloproteinase,planar cell polarity,podocyte
                Pathology
                glomerulus, kidney disease, matrix metalloproteinase, planar cell polarity, podocyte

                Comments

                Comment on this article